Medical Patent News

RSS

Neuren granted US patent for NNZ-2566

Neuren Pharmaceuticals has announced that its patent application entitled "GPE Analogs and Peptidomimetics" (PCT/US02/16361) has been issued in the United States (US Patent No: 7,041,314) on 9 May 2006.

10 May 2006

Primagen awarded U.S. patent for using mitochondrial DNA quantification as biomarker

Primagen Holding BV has announced that the U.S. Patent and Trademark Office has granted a patent for its Mitox mitochondrial DNA quantification technology as biomarkers for efficacy and adverse events of treatment.

19 Apr 2006

Patent filed for method to prevent early labor and premature delivery of low-birth-weight babies

The discovery is an incremental step in an area of obstetrics that has seen little improvement in 20 years.

28 Mar 2006

MedMira files patent for OTC testing system

MedMira has announced today that it has filed a provisional patent application for a system which enables over-the-counter (OTC) home testing and diagnosis of infectious diseases, such as HIV, hepatitis C, and other medical conditions.

23 Mar 2006

Sanofi-aventis and Bristol-Myers Squibb agree to settle patent dispute with Apotex

Sanofi-aventis and Bristol-Myers Squibb have announced that they have reached an agreement subject to certain conditions with Apotex to settle the patent infringement lawsuit pending between the parties in the U.S. District Court for the Southern District of New York.

21 Mar 2006

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

The patent which is assigned to the University of Pittsburgh has been exclusively licensed to PRP. The drug, known as PulmoLAR, containing 2ME as active ingredient, is currently developed by PRP for the treatment of pulmonary arterial hypertension (PAH).

21 Mar 2006

EntreMed announces new U.S. Patent - "Estrogenic Compounds as Anti-Mitotic Agents"

EntreMed has announced the issuance of U.S. Patent No. 7,012,070 covering methods of treatment for a broad range of indications with its lead clinical-stage compound, 2-methoxyestradiol (2ME2).

17 Mar 2006

Bioniche granted patent for oligonucleotide technology

Bioniche Life Sciences has announced that it has been granted a European patent - EP1432450 - covering the composition and use of a novel oligonucleotide family for the treatment of cancer entitled: "Therapeutically Useful Triethyleneglycol Cholesteryl Oligonucleotides"

17 Mar 2006

Third Wave Technologies issued "Invasive Cleavage of Nucleic Acids" patent

Third Wave Technologies has announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,011,944, entitled "Invasive Cleavage of Nucleic Acids," to the company.

17 Mar 2006

Sentillion sues for patent infringement

Sentillion, Inc., has announced that it has filed a patent infringement lawsuit against Carefx Corporation in the United States District Court of Delaware.

17 Mar 2006

HemoCue wins patent infringement suit

For more than two years, HemoCue AB and EKF-diagnostics GmbH, a company in Magdeburg, Germany, have been involved in a patent infringement suit.

14 Mar 2006

AstraZeneca starts patent infringement litigation against IVAX

AstraZeneca announced today that it has filed a lawsuit in the United States District Court for the District of New Jersey against IVAX Corporation, IVAX Pharmaceuticals and Zenith Laboratories

8 Mar 2006

GenoMed awarded second patent, for avoiding dialysis in acute kidney failure

GenoMed announced today that it received its second patent (US Patent #6,998,404) for the "Treatment or prevention of acute renal failure." Acute kidney failure usually happens when a patient gets dehydrated.

1 Mar 2006

BrainLAB wins patent infringement case

On Friday, the U.S. District Court in Denver, Colorado, dismissed the patent infringement lawsuit filed by Medtronic against BrainLAB in 1998.

27 Feb 2006

Takeda wins patent infringement case

Takeda Pharmaceutical Company Limited and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc. have announced that Takeda's intellectual property rights have been successfully asserted against generic manufacturers seeking to challenge Takeda's patent rights to ACTOS (pioglitazone HCl).

24 Feb 2006

Angiotech to appeal judgement regarding UK patent

Angiotech Pharmaceuticals has announced that it intends to appeal a UK trial court decision to revoke Angiotech's UK designation of its European Patent No. 0,706,376.

24 Feb 2006

Sentillion issued U.S. patent for technology for managing context sharing systems

Sentillion, Inc., the leading provider of identity and access management (IAM) solutions for the always-on healthcare industry, has received its third patent (U.S. Patent No. 6,993,556) from the United States Patent and Trademark Office.

21 Feb 2006

Oncolytics Biotech granted new patent

Oncolytics Biotech Inc. has been granted U.S. Patent 6,994,858 entitled "Reovirus Clearance of Ras-Mediated Neoplastic Cells from Mixed Cellular Compositions."

7 Feb 2006

Laserscope issued new U.S. patent

Laserscope announced today that it has been issued an important U.S. patent from the United States Patent and Trademark Office (USPTO) relating to the use of its Photoselective Vaporization (PV) method and technology for therapeutic treatment of benign prostatic hyperplasia (BPH) and other tissues in the human body.

26 Jan 2006

Patent losses open up $30 billion biologics market to generic competition

With powerhouse biologics, such as human growth hormone and insulin, losing their U.S. patent protection in 2005 and many more set to expire within the next 4 years, generic competition in the lucrative biopharmaceutical market is imminent, according to a new study from Kalorama Information.

25 Jan 2006

Medical Patent News

Neuren granted US patent for NNZ-2566

Primagen awarded U.S. patent for using mitochondrial DNA quantification as biomarker

Patent filed for method to prevent early labor and premature delivery of low-birth-weight babies

MedMira files patent for OTC testing system

Sanofi-aventis and Bristol-Myers Squibb agree to settle patent dispute with Apotex

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

EntreMed announces new U.S. Patent - "Estrogenic Compounds as Anti-Mitotic Agents"

Bioniche granted patent for oligonucleotide technology

Third Wave Technologies issued "Invasive Cleavage of Nucleic Acids" patent

Sentillion sues for patent infringement

HemoCue wins patent infringement suit

AstraZeneca starts patent infringement litigation against IVAX

GenoMed awarded second patent, for avoiding dialysis in acute kidney failure

BrainLAB wins patent infringement case

Takeda wins patent infringement case

Angiotech to appeal judgement regarding UK patent

Sentillion issued U.S. patent for technology for managing context sharing systems

Oncolytics Biotech granted new patent

Laserscope issued new U.S. patent

Patent losses open up $30 billion biologics market to generic competition

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News